首页> 美国卫生研究院文献>International Journal of Methods in Psychiatric Research >Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health Surveys
【2h】

Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health Surveys

机译:世界卫生组织世界心理健康调查中综合国际诊断访谈3.0版(CIDI 3.0)与标准化临床评估的一致性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The DSM‐IV diagnoses generated by the fully structured lay‐administered Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) in the WHO World Mental Health (WMH) surveys were compared to diagnoses based on follow‐up interviews with the clinician‐administered non‐patient edition of the Structured Clinical Interview for DSM‐IV (SCID) in probability subsamples of the WMH surveys in France, Italy, Spain, and the US. CIDI cases were oversampled. The clinical reappraisal samples were weighted to adjust for this oversampling. Separate samples were assessed for lifetime and 12‐month prevalence. Moderate to good individual‐level CIDI‐SCID concordance was found for lifetime prevalence estimates of most disorders. The area under the ROC curve (AUC, a measure of classification accuracy that is not influenced by disorder prevalence) was 0.76 for the dichotomous classification of having any of the lifetime DSM‐IV anxiety, mood and substance disorders assessed in the surveys and in the range 0.62–0.93 for individual disorders, with an inter‐quartile range (IQR) of 0.71–0.86. Concordance increased when CIDI symptom‐level data were added to predict SCID diagnoses in logistic regression equations. AUC for individual disorders in these equations was in the range 0.74–0.99, with an IQR of 0.87–0.96. CIDI lifetime prevalence estimates were generally conservative relative to SCID estimates. CIDI‐SCID concordance for 12‐month prevalence estimates could be studied powerfully only for two disorder classes, any anxiety disorder (AUC = 0.88) and any mood disorder (AUC = 0.83). As with lifetime prevalence, 12‐month concordance improved when CIDI symptom‐level data were added to predict SCID diagnoses. CIDI 12‐month prevalence estimates were unbiased relative to SCID estimates. The validity of the CIDI is likely to be under‐estimated in these comparisons due to the fact that the reliability of the SCID diagnoses, which is presumably less than perfect, sets a ceiling on maximum CIDI‐SCID concordance. Copyright © 2006 John Wiley & Sons, Ltd.
机译:在世界卫生组织(WHO)世界心理健康(WMH)调查中,由完全结构化的非常规管理的综合国际诊断访谈版本3.0(CIDI 3.0)生成的DSM-IV诊断与基于对临床医生管理的非常规诊断的随访访谈的诊断进行比较在法国,意大利,西班牙和美国进行的WMH调查概率子样本中的DSM-IV结构化临床访谈(SCID)的患者版本。 CIDI案例被过度抽样。对临床重新评估样品进行加权,以调整此过度采样。评估了单独的样本的终生和12个月患病率。对于大多数疾病的终生患病率估计,发现个人水平中等到良好的CIDI-SCID一致性。在二项分类中,在调查和评估中评估的任何一生的DSM-IV焦虑,情绪和物质障碍,ROC曲线下的面积(AUC,一种不受疾病患病率影响的分类准确性的度量)为0.76。个体疾病的范围为0.62-0.93,四分位间距(IQR)为0.71-0.86。当在逻辑回归方程中添加CIDI症状水平数据来预测SCID诊断时,一致性增加。这些方程式中单个疾病的AUC在0.74–0.99范围内,IQR为0.87–0.96。相对于SCID估计,CIDI终身患病率估计通常是保守的。仅对两种疾病类别(任何焦虑症(AUC = 0.88)和任何情绪障碍(AUC = 0.83))进行有力的研究,才能对12个月患病率估计的CIDI-SCID一致性进行有力的研究。与一生的患病率一样,通过添加CIDI症状水平数据来预测SCID诊断,可以改善12个月的一致性。相对于SCID估计,CIDI 12个月患病率估计没有偏见。在这些比较中,CIDI的有效性可能会被低估,原因是SCID诊断的可靠性(可能不尽人意)为CIDI-SCID的最大一致性设定了上限。版权所有©2006 John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号